Group Leader

The Group Leader will build and lead an interdisciplinary team developing antibody-oligonucleotide conjugates (AOCs) for extrahepatic delivery, integrating antibody discovery, linker chemistry, and bioanalytical validation. This role involves defining scientific strategy, establishing platform capabilities, and driving asset generation beyond established hepatic indications. The position requires leading cross-functional partnerships and managing program milestones to advance RNA-based therapeutics.